Skip to main content

Table 2 SerOzNET blood sampling schedule

From: Protocol for SARS-CoV-2 post-vaccine surveillance study in Australian adults and children with cancer: an observational study of safety and serological and immunological response to SARS-CoV-2 vaccination (SerOzNET)

Week (W) and day (D) of trial Pfizer
3-week interval
Astra Zeneca
6-week interval
Astra Zeneca
12-week interval
Moderna
4-week interval
*W0 D0 (− 7) Baseline Baseline Baseline Baseline
W3 D21 (± 3) 2nd dose   D21 post 1st dose  
W4 D28 (± 3)     2nd dose
W6 D42 (± 3)   2nd dose   
W7 D49 (± 1) 1 M post 2nd dose    
W8 D56     1 M post 2nd dose
W10 D70 (± 1)   1 M post 2nd dose   
W12 D84 (± 7)    2nd dose  
W15 D105 (± 7) *3 M post 2nd dose    
W16 D112 (± 1)    1 M post 2nd dose 3 M post 2nd dose
W18 D126 (± 7)   3 M post 2nd dose   
W24 D168 (± 7)    3 M post 2nd dose  
W27 D189 (± 7) 6 M post 2nd dose    
W28 D196 (± 7)     6 M post 2nd dose
  1. Additional vaccines can be added when available
  2. D day, W week, M month